Patents by Inventor Ji Min Mei

Ji Min Mei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040185496
    Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel S. aureus mutants useful in vaccines.
    Type: Application
    Filed: April 5, 2004
    Publication date: September 23, 2004
    Inventors: David W. Holden, Ji Min Mei
  • Patent number: 6740485
    Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and provision of novel S. aureus mutants useful in vaccines.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: May 25, 2004
    Assignee: Imperial College Innovations Limited
    Inventors: David W. Holden, Ji Min Mei
  • Publication number: 20030148346
    Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel S. aureus mutants useful in vaccines.
    Type: Application
    Filed: November 22, 2002
    Publication date: August 7, 2003
    Inventors: David Holden, Ji Min Mei
  • Patent number: 6485899
    Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel S. aureus mutants useful in vaccines.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: November 26, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: David Holden, Ji Min Mei
  • Patent number: 6455323
    Abstract: Staphylococcus aureus virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel S. aureus mutants useful in vaccines.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: September 24, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: David Holden, Ji Min Mei